PDRDX | RIDAX | PDRDX / RIDAX | |
Total Expense Ratio | 0.85 | 1.36 | 62% |
Annual Report Gross Expense Ratio | 0.90 | 1.36 | 66% |
Fund Existence | 15 years | 23 years | - |
Gain YTD | 9.787 | 12.609 | 78% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.44B | 137B | 2% |
Annual Yield % from dividends | 2.07 | 2.90 | 71% |
Returns for 1 year | 7.15 | 10.63 | 67% |
Returns for 3 years | 6.63 | 27.32 | 24% |
Returns for 5 years | 28.33 | 35.28 | 80% |
Returns for 10 years | 43.63 | 52.65 | 83% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPCX | 13.01 | 0.12 | +0.93% |
Saratoga Health & Biotechnology C | |||
SHISX | 60.58 | 0.30 | +0.50% |
BlackRock Health Sciences Opps Svc | |||
IIRSX | 13.27 | 0.06 | +0.45% |
Voya Russell Small Cap Index Port I | |||
ETLCX | 15.20 | 0.02 | +0.13% |
Eventide Large Cap Focus C | |||
SVSPX | 284.15 | -0.87 | -0.31% |
State Street S&P 500 Index N |